Literature DB >> 24948812

Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.

Xueqian Wang1, Christopher R Campos1, John C Peart1, Lindsay K Smith1, Jessica L Boni1, Ronald E Cannon1, David S Miller2.   

Abstract

Activation of nuclear factor E2-related factor-2 (Nrf2), a sensor of oxidative stress, is neuroprotective in animal models of cerebral ischemia, traumatic brain injury, subarachnoid hemorrhage, and spinal cord injury. We show here that Nrf2 activation with sulforaphane (SFN) in vivo or in vitro increases expression and transport activity of three ATP-driven drug efflux pumps at the blood-brain barrier [P-glycoprotein, ATP binding cassette b1 (Abcb1); multidrug resistance-associated protein-2 (Mrp2), Abcc2; and breast cancer resistance protein (Bcrp), Abcg2]. Dosing rats with SFN increased protein expression of all three transporters in brain capillaries and decreased by 50% brain accumulation of the P-glycoprotein substrate verapamil. Exposing rat or mouse brain capillaries to SFN increased P-glycoprotein, Bcrp, and Mrp2 transport activity and protein expression; SFN increased P-glycoprotein activity in mouse spinal cord capillaries. Inhibiting transcription or translation abolished upregulation of P-glycoprotein activity. No such effects were seen in brain capillaries from Nrf2-null mice, indicating Nrf2 dependence. Nrf2 signaled indirectly to increase transporter activity/expression. The p53 inhibitor pifithrin abolished the SFN-induced increase in transporter activity/expression, and the p53-activator nutlin-3 increased P-glycoprotein activity. SFN did not alter P-glycoprotein transport activity in brain and spinal cord capillaries from p53-null mice. Inhibitors of p38 MAPK and nuclear factor κB (NF-κB) blocked the effects of SFN and nutlin-3 on P-glycoprotein activity. These results implicate Nrf2, p53, and NF-κB in the upregulation of P-glycoprotein, Bcrp, and Mrp2 at blood-CNS barriers. They imply that the barriers are tightened selectively (efflux transporter upregulation) by oxidative stress, providing increased neuroprotection, but also reduced penetration of many therapeutic drugs.
Copyright © 2014 the authors 0270-6474/14/348585-09$15.00/0.

Entities:  

Keywords:  ABC transporters; NF-κB; P-glycoprotein; blood-brain barrier; drug delivery; p53

Mesh:

Substances:

Year:  2014        PMID: 24948812      PMCID: PMC4061395          DOI: 10.1523/JNEUROSCI.2935-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

Review 1.  Genetic mechanisms of susceptibility to oxidative lung injury in mice.

Authors:  Hye-Youn Cho; Steven R Kleeberger
Journal:  Free Radic Biol Med       Date:  2006-11-23       Impact factor: 7.376

2.  In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation.

Authors:  Björn Bauer; Xiaodong Yang; Anika M S Hartz; Emily R Olson; Rong Zhao; J Cory Kalvass; Gary M Pollack; David S Miller
Journal:  Mol Pharmacol       Date:  2006-07-12       Impact factor: 4.436

Review 3.  The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity.

Authors:  Ian M Copple; Christopher E Goldring; Neil R Kitteringham; B Kevin Park
Journal:  Handb Exp Pharmacol       Date:  2010

4.  Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents.

Authors:  Jing Zhao; Nobuhide Kobori; Jaroslaw Aronowski; Pramod K Dash
Journal:  Neurosci Lett       Date:  2005-10-17       Impact factor: 3.046

Review 5.  Regulation of hepatic transporters by xenobiotic receptors.

Authors:  C D Klaassen; A L Slitt
Journal:  Curr Drug Metab       Date:  2005-08       Impact factor: 3.731

6.  Sulforaphane improves cognitive function administered following traumatic brain injury.

Authors:  Pramod K Dash; Jing Zhao; Sara A Orsi; Min Zhang; Anthony N Moore
Journal:  Neurosci Lett       Date:  2009-04-15       Impact factor: 3.046

7.  Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier.

Authors:  Björn Bauer; Anika M S Hartz; Jonathan R Lucking; Xiaodong Yang; Gary M Pollack; David S Miller
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-19       Impact factor: 6.200

8.  Activation of Nrf2-ARE pathway in brain after traumatic brain injury.

Authors:  Wei Yan; Han-Dong Wang; Zhi-Gang Hu; Qing-Feng Wang; Hong-Xia Yin
Journal:  Neurosci Lett       Date:  2007-12-08       Impact factor: 3.046

9.  Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling.

Authors:  Björn Bauer; Anika M S Hartz; Anton Pekcec; Kathrin Toellner; David S Miller; Heidrun Potschka
Journal:  Mol Pharmacol       Date:  2007-12-19       Impact factor: 4.436

Review 10.  Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.

Authors:  Lauren M Aleksunes; José E Manautou
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

View more
  60 in total

1.  In utero exposure to di-(2-ethylhexyl) phthalate induces testicular effects in neonatal rats that are antagonized by genistein cotreatment.

Authors:  Steven Jones; Annie Boisvert; Sade Francois; Liandong Zhang; Martine Culty
Journal:  Biol Reprod       Date:  2015-08-26       Impact factor: 4.285

Review 2.  Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.

Authors:  Ludwik Gorczyca; Lauren M Aleksunes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-03-14       Impact factor: 4.481

Review 3.  Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.

Authors:  Wazir Abdullahi; Dinesh Tripathi; Patrick T Ronaldson
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

4.  Lysophosphatidic acid and amitriptyline signal through LPA1R to reduce P-glycoprotein transport at the blood-brain barrier.

Authors:  David B Banks; Gary Ny Chan; Rebecca A Evans; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-27       Impact factor: 6.200

5.  Tetrabromobisphenol A (TBBPA) Alters ABC Transport at the Blood-Brain Barrier.

Authors:  Ronald E Cannon; Andrew W Trexler; Gabriel A Knudsen; Rebecca A Evans; Linda S Birnbaum
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

6.  Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.

Authors:  Hisham Qosa; Jessica Lichter; Mark Sarlo; Shashirekha S Markandaiah; Kevin McAvoy; Jean-Philippe Richard; Michael R Jablonski; Nicholas J Maragakis; Piera Pasinelli; Davide Trotti
Journal:  Glia       Date:  2016-05-09       Impact factor: 7.452

Review 7.  Supplements, nutrition, and alternative therapies for the treatment of traumatic brain injury.

Authors:  Brandon P Lucke-Wold; Aric F Logsdon; Linda Nguyen; Ahmed Eltanahay; Ryan C Turner; Patrick Bonasso; Chelsea Knotts; Adam Moeck; Joseph C Maroon; Julian E Bailes; Charles L Rosen
Journal:  Nutr Neurosci       Date:  2016-10-05       Impact factor: 4.994

8.  PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression.

Authors:  Vijay R More; Christopher R Campos; Rebecca A Evans; Keith D Oliver; Gary Ny Chan; David S Miller; Ronald E Cannon
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

9.  In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice.

Authors:  Kazuto Yasuda; Cynthia Cline; Yvonne S Lin; Rachel Scheib; Samit Ganguly; Ranjit K Thirumaran; Amarjit Chaudhry; Richard B Kim; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2015-08-17       Impact factor: 3.922

10.  Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells.

Authors:  Shaymaa M M Yahya; Ahmed R Hamed; Mohamed Emara; Maha M Soltan; Gamal Eldein F Abd-Ellatef; Salma M Abdelnasser
Journal:  Tumour Biol       Date:  2015-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.